Walleye Capital
BHVN icon

Walleye Capital’s Biohaven BHVN Stock Holding History

Walleye Capital’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,100
Closed -$51.6K – 4751
2026
Q1 		$51.6K Sell
6,100
-7,000
-53% -$76.6K ﹤0.01% 3894
2025
Q4 		$148K Buy
13,100
+8,800
+205% +$109K ﹤0.01% 3692
2025
Q3 		$64.5K Sell
4,300
-2,600
-38% -$37.8K ﹤0.01% 3905
2025
Q2 		$97.4K Buy
6,900
+3,200
+86% +$57K ﹤0.01% 3787
2025
Q1 		$88.9K Buy
+3,700
New +$130K ﹤0.01% 3667
2024
Q1 		– Sell
-1,300
Closed -$55.6K – 5426
2023
Q4 		$55.6K Sell
1,300
-2,100
-62% -$65.3K ﹤0.01% 4267
2023
Q3 		$88.4K Buy
+3,400
New +$70.7K ﹤0.01% 3997
2023
Q2 		– Sell
-2,200
Closed -$30.1K – 4323
2023
Q1 		$30.1K Buy
+2,200
New +$35K ﹤0.01% 3314

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Capital's BHVN Position: Q2 2026 in Review

Walleye Capital sold out of Biohaven (BHVN) in Q2 2026, closing a stake of 203,477 shares — an estimated $1.72M sold.

Walleye Capital first reported a position in BHVN in Q2 2023 and held it in 10 quarters. The position peaked at $10.4M in Q3 2023. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Walleye Capital reported no remaining Biohaven position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 203,477 Biohaven shares in Q2 2026, an estimated $1.72M.
  • Walleye Capital first reported a position in Biohaven in Q2 2023 and held it in 10 quarters.
  • Walleye Capital's Biohaven position peaked at $10.4M in Q3 2023.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.